[Apex] Announcement regarding the expiration of the term of the 1st Sustainability Committee

Apex Medical Corp announced that the term of its 1st Sustainability Committee has expired in conjunction with the expiration of the Board of Directors' term. New members have not yet been appointed and will be announced following the board's decision.
人事NQ 67/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: June 5, 2026 at 09:00
  • 🔍 Collected: June 6, 2026 at 08:00 (23h 0m after Published)
  • 🤖 AI Analyzed: June 7, 2026 at 05:09 (21h 9m after Collected)
1. Date of change: 2026/06/05 (115/06/05)
2. Name of functional committee: Sustainability Committee
3. Names of outgoing members:
Xu Huanqing, Guo Zhenghong, Chen Huiyou, Liu Hengyi, Wang Yajun, Wei Xiuming
4. Profiles of outgoing members:
Xu Huanqing: Chairman of the Board
Guo Zhenghong: Independent Director
Chen Huiyou: Independent Director
Liu Hengyi: Independent Director
Wang Yajun: Director and General Manager
Wei Xiuming: Chief Financial Officer
5. Names of incoming members: Not yet appointed
6. Profiles of incoming members: Not yet appointed
7. Type of change (resignation, dismissal, expiration of term, death, or new appointment):
Expiration of term
8. Reason for change: In accordance with the expiration of the Board of Directors' term, the term of the Sustainability Committee is the same as the Board's term.
9. Original term (format: xx/xx/xx ~ xx/xx/xx): 2024/03/25 ~ 2026/06/11 (113/03/25 ~ 115/06/11)
10. Effective date of new appointment: N/A
11. Other notes: The 2nd Sustainability Committee members will be announced separately after being appointed by the Board of Directors.

FAQ

What is the function of the Apex Medical sustainability committee?

It oversees and promotes the company's ESG goals and sustainable business strategies.

When will the new members be announced?

They will be formally announced once the board of directors selects the next committee members.

Will this announcement affect stock price?

This is a standard governance procedure regarding officer terms and is unlikely to be a direct factor for market volatility.